How groundbreaking therapy could help the brain heal after stroke

Every year, millions of lives are suddenly, rapidly changed by a stroke, which occurs when a blood vessel leading to the brain becomes blocked, causing neurons to die. Stroke is one of the leading causes of disability in adults, and it is estimated that one in six people will suffer a stroke at some point in their lives.

The human brain is by far the most complex organ in our body. Its sophisticated cellular architecture and neural networks provide us with language, memory, and abstract reasoning. But this complexity comes at a cost, as brain tissue has a very limited ability to regenerate. Unlike skin or liver tissue, dying neurons are rarely replaced.

so Brain Injuries are the root cause of many age-related diseases. One of the most serious and common of these is ischemic strokeCaused by a blockage in blood flow to an area of ​​the brain. Although advances in emergency treatment have improved survival rates, this is not currently the case Treatment Capable of repairing neuronal damage caused by stroke.

Rehabilitation helps restore some functions, but in many cases stroke survivors remain with permanent motor and cognitive impairments, as well as increased risk of depression, dementia, and other neurodegenerative diseases. However, this may soon change thanks to developments stem cellbased treatment.

A new therapeutic horizon

In recent decades, cell therapy has opened the door to a new generation of treatments in regenerative medicine. These are therapies that attempt to replace or repair damaged tissue by introducing new ones. cells Capable of surviving, maturing, and eventually regaining lost functions.

This is especially important for conditions that affect the brain. Despite its high potential, regenerative medicine has developed relatively slowly because it needs to comply with legislation in various areas. It also requires large financial investments.

An important precedent occurred in the late 1980s at Lund University Hospital in Sweden, where a team led by Anders Björklund and Ole Lindwall successfully transplanted neural stem cells into the brains of patients with Parkinson’s disease. Parkinson’s is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons, which are essential for controlling body movement.

The results were extraordinary: By replacing damaged neurons, many patients regained motor function for more than a decade. These experiments provided the first solid evidence that the human brain could be repaired using living cells.

Since then, research has advanced, techniques have been refined, and European regulations have established strict frameworks to ensure the safety and quality of these treatments, which are now classified as advanced therapy medicinal products. Currently, various clinical trials are underway around the world that continue the work of Björklund and Lindwall, and provide hope to patients with Parkinson’s and many other diseases that affect the brain.

Unique Challenge of Strokes

Although this story inspired many studies, stroke presents a different challenge to Parkinson’s disease. Ischemic damage is usually more extensive. It does not affect just one cell type, but multiple populations of neurons, glial cells, and blood vessels.

Furthermore, it is not enough for the transplanted cells to simply survive in the patient’s brain – they must become functionally integrated. This means that they need to send out their axons (extensions that transmit nerve impulses) and establish synapses or proper connections with living neurons that form part of the brain circuits.

This is equivalent to rebuilding both a broken bridge and the traffic crossing it: the connection must be established correctly for information to flow. So, in addition to adding new cells, the challenge of stroke is to effectively rewire the brain.

The promise of genetic engineering

This is where genetic engineering, one of the most transformative technologies in modern biology, comes into play. This discipline allows cells to be modified to be more effective, more resistant or better able to integrate into damaged tissues.

In our case, we inserted into the transplanted cells the gene that encodes the BDNF (brain-derived neurotrophic factor) protein, a neurotrophic factor that aids brain development and promotes axon growth and synapse formation. Its purpose is to facilitate the functional integration of new neurons into the injured brain, a key step in ensuring that the transplant not only fills a gap, but also restores neuronal communication.

question of morality

Genetic manipulation also raises ethical dilemmas, particularly with regard to the limits of its application and its potential long-term effects. For example, the above transplants in Parkinson’s patients were done with cells from fetal tissue.

Today, thanks to the work of Japanese researcher Shinya Yamanaka, winner of the 2012 Nobel Prize in Medicine, and his discovery of induced pluripotent stem cells (iPS), it is possible to generate stem cells from a patient’s own adult cells. It is now very common to generate iPS cells in the laboratory from skin biopsies.

This avoids many of the ethical conflicts associated with the use of embryos, and reduces the risk of immune rejection. Therefore, the question is no longer whether we can modify cells to repair the brain, but rather which criteria to use, under what rules, and with what responsibility.

The history of medicine is made up of small victories against the impossible. A few decades ago, the idea of ​​repairing a brain damaged by stroke seemed completely unimaginable. Today, thanks to a combination of biology, genetic engineering and regenerative medicine, it is beginning to take shape in laboratories. Many challenges still remain to be solved, but each new advance reminds us of something essential: The brain can not only learn, but it can also be repaired.